Recomendaciones preventivas vasculares. Actualización PAPPS 2024

Domingo Orozco-Beltrán; Carlos Brotons-Cuixart; José R. Banegas; Vicente F. Gil-Guillen; Ana M. Cebrián-Cuenca; Enrique Martín-Rioboó; Ariana Jordá-Baldó; Johanna Vicuña; Jorge Navarro-Pérez

doi:10.1016/j.aprim.2024.103123

journal article Open Access Nov 01, 2024

Recomendaciones preventivas vasculares. Actualización PAPPS 2024

Domingo Orozco-Beltrán Carlos Brotons-Cuixart José R. Banegas Vicente F. Gil-Guillen Ana M. Cebrián-Cuenca Enrique Martín-Rioboó Ariana Jordá-Baldó Johanna Vicuña Jorge Navarro-Pérez

Atención Primaria Vol. 56 pp. 103123 · Elsevier BV

View at Publisher Save 10.1016/j.aprim.2024.103123

Topics

No keywords indexed for this article. Browse by subject →

References

408

[1]

Instituto Nacional de Estadística. INE [Internet]. Salud. [consultado 8 Jun 2024]. Disponible en: https://www.ine.es/dyngs/INEbase/es/categoria.htm?c=Estadistica_P&cid=1254735573175.

[2]

Pérez-Villacastín J, Macaya C. Coincidiendo con la pandemia, la mortalidad cardiovascular vuelve a crecer. Sociedad Española de Cardiología. 2021. [consultado 8 Jun 2024]. Disponible en: https://secardiologia.es/comunicacion/notas-de-prensa/notas-de-prensa-sec/13104-coincidiendo-con-la-pandemia-la-mortalidad-cardiovascular-vuelve-a-crecer.

[3]

Soriano "The burden of disease in Spain: Results from the Global Burden of Disease 2016" Med Clin. (2018) 10.1016/j.medcli.2018.05.011

[4]

European Society of Cardiology: cardiovascular disease statistics 2021

Adam Timmis, Panos Vardas, Nick Townsend et al.

European Heart Journal 2022 10.1093/eurheartj/ehab892

[5]

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Frank L J Visseren, François Mach, Yvo M Smulders et al.

European Heart Journal 2021 10.1093/eurheartj/ehab484

[6]

Mostaza "SEA 2024 Standards for Global Control of Vascular Risk" Clin Investig Arterioscler. (2024)

[7]

2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

Reinhold Kreutz, Mattias Brunström, Michel Burnier et al.

European Journal of Internal Medicine 2024 10.1016/j.ejim.2024.05.033

[8]

Gijón-Conde "[Spanish Society of Hypertension position statement on the 2017 ACC/AHA hypertension guidelines]" Hipertens Riesgo Vasc. (2018)

[9]

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

Eleni Rapsomaniki, Adam Timmis, Julie George et al.

The Lancet 2014 10.1016/s0140-6736(14)60685-1

[10]

Mostaza "SEA 2022 Standards for Global Control of Cardiovascular Risk" Clin Investig Arterioscler. (2022)

[11]

Williams "2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension" Blood Press. (2018) 10.1080/08037051.2018.1527177

[12]

CDC. Smoking and Tobacco Use. 2024. Health problems caused by secondhand smoke. [consultado 4 Jun 2024]. Disponible en: https://www.cdc.gov/tobacco/secondhand-smoke/health.html.

[13]

World Health Organization. Gender and health. [consultado 5 Jun 2024]. Disponible en: https://www.who.int/health-topics/gender.

[14]

O’Neil "Gender/Sex as a Social Determinant of Cardiovascular Risk" Circulation. (2018) 10.1161/circulationaha.117.028595

[15]

Woodward "Cardiovascular Disease and the Female Disadvantage" Int J Environ Res Public Health [Internet] (2019) 10.3390/ijerph16071165

[16]

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women

Leslie Cho, Melinda Davis, Islam Elgendy et al.

Journal of the American College of Cardiology 2020 10.1016/j.jacc.2020.03.060

[17]

Patient–physician gender concordance and increased mortality among female heart attack patients

Brad N. Greenwood, Seth Carnahan, Laura Huang

Proceedings of the National Academy of Sciences 2018 10.1073/pnas.1800097115

[18]

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven Hageman, Lisa Pennells, Francisco Ojeda et al.

European Heart Journal 2021 10.1093/eurheartj/ehab309

[19]

"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions" Eur Heart J [Internet] (2021) 10.1093/eurheartj/ehab312

[20]

ORTEC in Health care and science. U-Prevent, for the application of risk prediction models in clinical practice. [consultado Oct 2024]. Disponible en: https://u-prevent.com.

[21]

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

Lisa Pennells, Stephen Kaptoge, Helena Bleken Østergaard et al.

European Heart Journal 2023 10.1093/eurheartj/ehad260

[22]

Matsushita "Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP" Eur J Prev Cardiol. (2023) 10.1093/eurjpc/zwac176

[23]

Gómez Gerique "Improvement of serum lipids concentration in a general population historical cohort. Why?" Clin Investig Arterioscler. (2017)

[24]

Marín "Risk of ischaemic heart disease and acute myocardial infarction in a Spanish population: observational prospective study in a primary-care setting" BMC Public Health. (2006) 10.1186/1471-2458-6-38

[25]

User S. The Catalonia Study [Internet]. [consultado 5 Jun 2024]. Disponible en: http://www.biomarcare.eu/the-cohorts-biomarcare/24-population-based-cohorts/43-the-catalonia-study.

[26]

Zeller "BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries" Eur J Epidemiol. (2014) 10.1007/s10654-014-9952-x

[27]

International Agency for Research on Cancer. The EPIC-CVD working group [Internet]. [consultado5 Jun 2024]. Disponible en: https://epic.iarc.fr/research/epic-cvd/.

[28]

Østergaard "Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)" Eur J Prev Cardiol. (2023) 10.1093/eurjpc/zwac232

[29]

Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association

Sadiya S. Khan, Josef Coresh, Michael J. Pencina et al.

Circulation 2023 10.1161/cir.0000000000001191

[30]

Brotons "Estimation of Lifetime Risk of Cardiovascular Disease (IBERLIFERISK): A New Tool for Cardiovascular Disease Prevention in Primary Care" Rev Esp Cardiol. (2019) 10.1016/j.recesp.2018.05.002

[31]

Quesada "Machine learning to predict cardiovascular risk" Int J Clin Pract. (2019) 10.1111/ijcp.13389

[32]

Orozco-Beltrán "[Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS]" Aten Primaria. (2022) 10.1016/j.aprim.2022.102444

[33]

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension

Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström et al.

Journal of Hypertension 2023 10.1097/hjh.0000000000003480

[34]

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Thomas Unger, Claudio Borghi, Fadi Charchar et al.

Hypertension 2020 10.1161/hypertensionaha.120.15026

[35]

Campbell "2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas" Lancet Reg Health Am. (2022)

[36]

2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement

George Stergiou, Paolo Palatini, Gianfranco Parati et al.

Journal of Hypertension 2021 10.1097/hjh.0000000000002843

[37]

Gorostidi "Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión - Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA)" Hiperten Riesgo Vasc. (2022) 10.1016/j.hipert.2022.09.002

[38]

Rabi "Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children" Can J Cardiol. (2020) 10.1016/j.cjca.2020.02.086

[39]

"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease" Kidney Int. (2021)

[40]

Hypertension in adults: diagnosis and management [Internet]. London: National Institute for Health and Care Excellence (NICE); [consultado 8 Jun 2024]. Disponible en: https://r.ncbi.nlm.nih.gov/pubmed/31577399.

[41]

2024 ESC Guidelines for the management of elevated blood pressure and hypertension

John William McEvoy, Cian P McCarthy, Rosa Maria Bruno et al.

European Heart Journal 2024 10.1093/eurheartj/ehae178

[42]

"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants" Lancet (2021) 10.1016/s0140-6736(21)01330-1

[43]

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

The Lancet 2002 10.1016/s0140-6736(02)11911-8

[44]

Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019

Juan A. Divison-Garrote, Julio A. Carbayo-Herencia, Marta Simarro-Rueda et al.

Hypertension 2023 10.1161/hypertensionaha.123.21732

[45]

Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

Mohammad H. Forouzanfar, Patrick Liu, Gregory A. Roth et al.

JAMA 2017 10.1001/jama.2016.19043

[46]

Banegas "Numerical values and impact of hypertension in Spain" Rev Esp Cardiol. (2024) 10.1016/j.recesp.2024.03.002

[47]

Banegas "[The IBERICAN Project. Progressing in the knowledge of cardiovascular risk in primary care in Spain]" Semergen. (2020) 10.1016/j.semerg.2019.12.001

[48]

Cohorte IMPaCT [Internet]. [consultado 9 Jun 2024]. Disponible en: https://cohorte-impact.es/.

[49]

Prieto-Díaz "Clinical characteristics, treatment, and blood pressure control in patients with hypertension seen by primary care physicians in Spain: the IBERICAN study" Front Cardiovasc Med. (2023) 10.3389/fcvm.2023.1295174

[50]

Banegas "Trends in hypertension control among the older population of Spain from 2000 to 2001 to 2008 to 2010: role of frequency and intensity of drug treatment" Circ Cardiovasc Qual Outcomes. (2015) 10.1161/circoutcomes.114.001191

Showing 50 of 408 references

Metrics

6

Citations

408

References

Details

Published: Nov 01, 2024
Vol/Issue: 56
Pages: 103123
License: View

Authors

D

Domingo Orozco-Beltrán

C

Carlos Brotons-Cuixart

J

José R. Banegas

V

Vicente F. Gil-Guillen

A

Ana M. Cebrián-Cuenca

E

Enrique Martín-Rioboó

Cite This Article

Domingo Orozco-Beltrán, Carlos Brotons-Cuixart, José R. Banegas, et al. (2024). Recomendaciones preventivas vasculares. Actualización PAPPS 2024. Atención Primaria, 56, 103123. https://doi.org/10.1016/j.aprim.2024.103123

Recomendaciones preventivas vasculares. Actualización PAPPS 2024

You May Also Like